文献速递重症综合管理与镇静镇痛

高龄与超高龄患者入住重症监护室的特征、结局与并发症:范围综述

Characteristics, outcomes, and complications among nonagenarian and centenarian patients admitted to the intensive care unit: a scoping review.
PubMed 文献 · Crit Care · 2025-03-13
一句话结论90岁以上ICU患者虽合并症多、住院时间长,但约五分之四存活至出院、半数存活至一年,作者认为经审慎筛选ICU治疗可有意义且有益。

本范围综述纳入36项研究(多为回顾性,含1项国家质量登记研究及1项两大多国队列前瞻性分析),共16,859例患者,平均年龄92.4岁,男性占39.3%。多数患者存在多种合并症;总体40.7%接受机械通气,机械通气时间均值90.4小时、中位数84小时;心血管与肾脏并发症常见。ICU住院均值5.4天、中位数5天,医院住院中位数12.4天;医院死亡率中位数25.55%,6个月与1年死亡率均值分别为38.6%和45.6%。作者认为约五分之四存活至出院、半数存活至一年,经审慎筛选ICU治疗可有意义且有益,并呼吁建立标准化报告结构。

要点

  • 36项研究共16,859例90岁以上ICU患者,平均年龄92.4岁,男性39.3%,多数存在多种合并症。
  • 总体40.7%接受机械通气,机械通气时间均值90.4小时(中位数84小时,范围10-221小时)。
  • 医院死亡率中位数25.55%(范围0%-62.5%;IQR 15%-35.5%),6个月与1年死亡率均值分别为38.6%和45.6%。
  • ICU住院均值5.4天(中位数5天),医院住院中位数12.4天,心血管与肾脏并发症常见。
  • 作者认为经审慎筛选,ICU治疗对90岁以上患者可有意义且有益,并呼吁标准化报告结构。

适用人群与场景

  • 入住ICU的90岁及以上(高龄与超高龄)患者,为范围综述所纳入36项研究的人群。

研究设计与关键结果

  • 研究设计:范围综述,纳入36项研究,多为回顾性,其中1项为国家质量登记研究、1项为两大多国队列的前瞻性分析;共16,859例患者,平均年龄92.4岁,男性占39.3%。
  • 多数患者存在多种合并症;心血管与肾脏并发症常见。
  • 总体40.7%接受机械通气,各研究中位数为36%(范围0%-100%;IQR 23.8%-50%);机械通气时间均值90.4小时,中位数84小时(范围10-221小时;IQR 12.25-146.5小时)。
  • ICU住院均值5.4天,中位数5天(范围0.9-13天;IQR 2.55-7.03天);医院住院中位数12.4天(范围5.7-31天;IQR 11-17.6天)。
  • 医院死亡率中位数25.55%(范围0%-62.5%;IQR 15%-35.5%);6个月死亡率均值38.6%,1年死亡率均值45.6%。
  • 作者据此指出约五分之四患者存活至出院、半数存活至一年。

证据类型、等级与局限

  • 证据类型:范围综述(纳入研究多为回顾性,含1项国家质量登记研究及1项两大多国队列的前瞻性分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,通过审慎的患者选择,ICU治疗对90岁以上患者可有意义且有益。
  • 作者认为需建立针对入住ICU的90岁以上患者的标准化报告结构,以实现研究间可比性、提高数据质量与可靠性、提升研究效率并更好识别该脆弱人群的独特健康需求。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Nonagenarians and centenarians are a growing and vulnerable groups of patients admitted to ICU. There is limited information on their characteristics, outcomes, and complications.

METHODS: We performed a scoping review of studies focused on nonagenarians and centenarians admitted to ICU. We assessed their characteristics, the presence of frailty, the presence of comorbidities, their complications, their ICU and hospital length of stay and mortality and their long-term outcomes.

RESULTS: We assessed 36 studies, mostly retrospective, with one classified as a National Quality Registry study and another as a prospective analysis of two large multinational cohorts. The studies involved 16,859 patients with a mean age of 92.4 years and a male prevalence of 39.3%. Multiple comorbidities were present in the majority of patients. Overall, 40.7% of patients received mechanical ventilation, with a median of 36% (range: 0%-100%; IQR: 23.8%-50%). Mean duration of mechanical ventilation was 90.4 h, with a median of 84 h (range: 10-221 h; IQR: 12.25-146.5 h). Cardiovascular and renal complications were common. Mean ICU stay across studies was 5.4 days, with a median of 5 days (range: 0.9-13 days; IQR: 2.55-7.03 days). The median length of hospital stay was 12.4 days (range: 5.7-31 days; IQR: 11-17.6 days). The median hospital mortality was 25.55% (range: 0%-62.5%; IQR: 15%-35.5%). The mean six-month and 1-year mortality rates were 38.6% and 45.6%, respectively.

CONCLUSIONS: Nonagenarians and centenarians admitted to ICU are a highly comorbid and vulnerable population who experience prolonged hospital stays and complications. However four out of five survive to hospital discharge and half are alive at one year after admission. Therefore, through judicious patient selection, ICU care can be both meaningful and beneficial. Our findings underscore the need for a standardized reporting structure for nonagenarians and centenarians admitted to the ICU to allow comparability across studies, enhanced data quality and reliability, greater research efficiency, and better identification of the unique health needs in this vulnerable patient cohort.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Suh JM, Raykateeraroj N, Waldman B, et al. Characteristics, outcomes, and complications among nonagenarian and centenarian patients admitted to the intensive care unit: a scoping review. Crit Care. 2025. PMID: 40083001. doi:10.1186/s13054-025-05349-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。